Discovery of new molecular subtypes in oesophageal adenocarcinoma.
A large number of patients suffering from oesophageal adenocarcinomas do not respond to conventional chemotherapy; therefore, it is necessary to identify new predictive biomarkers and patient signatures to improve patient outcomes and therapy selections. We analysed 87 formalin-fixed and paraffin-em...
Guardado en:
Autores principales: | Daniela Berg, Claudia Wolff, Rupert Langer, Tibor Schuster, Marcus Feith, Julia Slotta-Huspenina, Katharina Malinowsky, Karl-Friedrich Becker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/999b038ba7a44b0f988a417d09262fb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.
por: Julia Slotta-Huspenina, et al.
Publicado: (2012) -
Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts
por: Eric Smith, et al.
Publicado: (2017) -
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
por: Sabina Berezowska, et al.
Publicado: (2013) -
Adenocarcinoma with Mixed Subtypes in the Early and Advanced Gastric Cancer
por: Xixian Zhao, et al.
Publicado: (2021) -
Histological assessment of PAXgene tissue fixation and stabilization reagents.
por: Marcel Kap, et al.
Publicado: (2011)